Increased awareness during the COVID-19 crisis and public efforts to strengthen the development of healthcare technologies has boosted the smart medical devices sector.
The continued threat of COVID-19 and prevalence of cardiac disorders are some of the key factors driving telemedicine industry expansion worldwide.
As organizations continue to use technology to enhance the way they provide care, changes must be made to ensure the interoperability of the technology, patient data and continuity between providers.
Telemedicine and remote monitoring became one of the defining medtech trends of the last year, and they show no signs of slowing.
COVID-19 ushered in a fundamental change in how medicine is being delivered.
To better understand the future of telehealth, it is important to understand what the costs look like over time and whether telehealth offers advantages in cutting healthcare costs overall.
Increased access to care is a vital part of the vision to innovate the delivery of healthcare.
As restrictions lift and in-person visits become viable again, the use of virtual care technology — particularly telemedicine and remote patient monitoring (RPM)—is here to stay.
During this week’s Consumer Electronics Show, FDA Principal Deputy Commissioner Amy Abernathy talks about lessons learned from the pandemic and 2021 goals.
Its success lies in a synergy between the technological and the clinical.